Amine precursors and depression

Arch Gen Psychiatry. 1975 Jan;32(1):22-30. doi: 10.1001/archpsyc.1975.01760190024002.

Abstract

The amino acid precursors, levodopa and L-tryptophan, were given to a group of hospitalized depressed patients in a double-blind placebo controlled study. Relatively large doses were not associated with sufficient clinical improvement to allow the patients to leave the hospital. Previous studies using the precursor-load strategy have produced conflicting findings on the use of these compounds for depressed patients.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Bipolar Disorder / drug therapy
  • Clinical Trials as Topic
  • Depression / drug therapy*
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Placebos
  • Psychiatric Status Rating Scales
  • Recurrence
  • Tryptophan / therapeutic use*

Substances

  • Placebos
  • Levodopa
  • Tryptophan